Annals On Call Podcast

American College of Physicians
undefined
Jan 19, 2026 • 21min

Dulaglutide, Semaglutide, and Tirzepatide: How do Gastrointestinal Side Effects Compare?

Dr. Centor discusses the comparative risk for severe gastrointestinal adverse events associated with dulaglutide, semaglutide, and tirzepatide with Dr. Wajd Alkabbani.
undefined
Jan 5, 2026 • 23min

Mediterranean Diet in the Management of Irritable Bowel Syndrome

Dr. Centor discusses dietary interventions for patients with irritable bowel syndrome with Dr. Imran Aziz.
undefined
Dec 15, 2025 • 25min

Complications Associated With Transvenous Cardiac Implantable Devices

Dr. Centor discusses complications of cardiac implantable electronic devices with Dr. Peter Zimetbaum.
undefined
Dec 1, 2025 • 25min

Cost-Effectiveness of Weight Loss Drugs for Knee Osteoarthritis

Dr. Centor discusses the use of weight loss drugs to treat patients with knee osteoarthritis with Dr. David Felson.
undefined
Nov 17, 2025 • 20min

Palliative Care: A Family Perspective

Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.
undefined
Nov 3, 2025 • 16min

What You May Have Missed in 2024: Part 3

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
undefined
Oct 20, 2025 • 14min

What You May Have Missed in 2024 - Part 2

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
undefined
Oct 6, 2025 • 29min

High-Concentration Cannabinoids: Are They Safe?

Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
undefined
Sep 15, 2025 • 20min

What You May Have Missed in 2024: Part 1

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
undefined
7 snips
Sep 1, 2025 • 23min

Fibrillation - When Ablation is the Way to Go

Dr. Peter Zimetbaum, a leading expert in cardiovascular medicine from Harvard, delves into the growing prevalence of atrial fibrillation and the emerging role of ablation therapy. He discusses a compelling meta-analysis that highlights ablation's advantages over medication in reducing long-term stroke risk. Zimetbaum also shares insights on the innovative pulse-field ablation technique, which ensures safer, quicker procedures. Additionally, he addresses the integration of ablation for patients with heart failure and the importance of anticoagulation decisions post-procedure.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app